Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the income generated from desktop review fees submitted by companies applying to the Coronavirus Test Devices Approval (CTDA) process has been reinvested to ensure that the newly introduced regulator operates proficiently and at a high standard.

The Coronavirus Test Devices Approval (CTDA) process operates on a cost recovery basis and does not generate any income from its desktop review fees, in excess of expenses incurred in the carrying out of its core duties. All revenue generated is offset against the cost of running the CTDA process.